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  3                        TC2 - How do I choose the correct disease-modifying treatment?         TC2.1 -- TC2.3
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  55                       PS10 - Immune mechanisms                                               PS10.1 -- PS10.6
  58                       PS11 - Gray matter pathology and mechanisms of progression             PS11.1 -- PS11.6
  60                       PS12 - Study design and endpoints                                      PS12.1 -- PS12.6
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  64                       HT5 - Inflammation and neurodegeneration                               HT5.1 -- HT5.3
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